These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25229195)

  • 1. Realizing the potential of patient organizations in translational research-delivering treatments for rare diseases.
    Berlin AC; Eggan ER
    Acad Med; 2014 Nov; 89(11):1573. PubMed ID: 25229195
    [No Abstract]   [Full Text] [Related]  

  • 2. [The academy of ideas].
    Bellasi A; Becherucci F; Bruno S; Esposito P; Gentile G; Netti S; Papale M; Ricci D; Salvi E; Trepiccione F; Zacchia M; Castellano G
    G Ital Nefrol; 2013; 30(2):. PubMed ID: 25077330
    [No Abstract]   [Full Text] [Related]  

  • 3. French institute prepares for gene-therapy push.
    Abbott A
    Nature; 2012 Jan; 481(7382):423-4. PubMed ID: 22281573
    [No Abstract]   [Full Text] [Related]  

  • 4. Translational units in occupational health: an innovative operational concept?
    Descatha A
    Br J Hosp Med (Lond); 2013 Dec; 74(12):706-7. PubMed ID: 24416786
    [No Abstract]   [Full Text] [Related]  

  • 5. The Care Continuum: An Evolving Model for Care and Research in Rare Diseases.
    Augustine EF; Dorsey ER; Saltonstall PL
    Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28818836
    [No Abstract]   [Full Text] [Related]  

  • 6. The national eye institute: translational clinical research initiatives on inherited and orphan retinal diseases: personal observations.
    Sieving PA
    Retina; 2005 Dec; 25(8 Suppl):S8-S9. PubMed ID: 16374351
    [No Abstract]   [Full Text] [Related]  

  • 7. Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.
    Austin CP; Cutillo CM; Lau LPL; Jonker AH; Rath A; Julkowska D; Thomson D; Terry SF; de Montleau B; Ardigò D; Hivert V; Boycott KM; Baynam G; Kaufmann P; Taruscio D; Lochmüller H; Suematsu M; Incerti C; Draghia-Akli R; Norstedt I; Wang L; Dawkins HJS;
    Clin Transl Sci; 2018 Jan; 11(1):21-27. PubMed ID: 28796445
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutics: Boost to translational medicine in Europe.
    Migliaccio G; de Man FH; Ussi AE
    Nature; 2013 May; 497(7451):565. PubMed ID: 23719452
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.
    Waldman SA; Terzic A
    Clin Transl Sci; 2011 Feb; 4(1):69-71. PubMed ID: 21348959
    [No Abstract]   [Full Text] [Related]  

  • 10. National Research Center for Translational Medicine · Shanghai-National Key Scientific Infrastructure for Translational Medicine.
    Wen CJ; Chen SJ
    Sci China Life Sci; 2016 Oct; 59(10):1051-1054. PubMed ID: 27520827
    [No Abstract]   [Full Text] [Related]  

  • 11. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 12. Focused interests.
    Peota C
    Minn Med; 2014 Oct; 97(10):16-9. PubMed ID: 25651628
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rare diseases: Innovation laboratories for human health].
    Braun S
    Presse Med; 2012 May; 41 Suppl 1():S48-50. PubMed ID: 22464890
    [No Abstract]   [Full Text] [Related]  

  • 14. From research to breakthrough treatments. Mayo Clinic is a leader in translational research.
    Mayo Clin Health Lett; 2012 Oct; Suppl():1-8. PubMed ID: 23133860
    [No Abstract]   [Full Text] [Related]  

  • 15. Documenting rare disease data in China.
    Lin H; Long E; Chen W; Liu Y
    Science; 2015 Sep; 349(6252):1064. PubMed ID: 26339020
    [No Abstract]   [Full Text] [Related]  

  • 16. Panel backs new NIH center devoted to translational medicine.
    Vastag B
    Nat Med; 2011 Jan; 17(1):5. PubMed ID: 21217653
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients often go without effective new treatments, especially in rare disease patient populations where profit potential is limited.
    Bloom BE
    Contemp Clin Trials; 2011 Mar; 32(2):151-2. PubMed ID: 21238613
    [No Abstract]   [Full Text] [Related]  

  • 18. From bench to practice to population health impact: barriers to realizing the public health and clinical promise of basic scientific discovery.
    Field A; Baxter K; Terry SF
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):191-2. PubMed ID: 21428744
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial.
    Taruscio D
    Public Health Genomics; 2013; 16(6):257-8. PubMed ID: 24503585
    [No Abstract]   [Full Text] [Related]  

  • 20. Power of rare diseases: found in translation.
    Fishman MC
    Sci Transl Med; 2013 Sep; 5(201):201ps11. PubMed ID: 24005157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.